the Sequential Therapy of CD19-targeted and CD20-targeted CAR-T Cell Therapy for Diffuse Large B Cell Lymphoma(DLBCL)
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:September 7, 2016Unknown status
Hide Studies Not Open or Pending
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:September 7, 2016Unknown status
Condition(s):Pneumococcal Infections; Lymphoma, Large B-Cell, DiffuseLast Updated:November 5, 2020Recruiting
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:March 23, 2020Completed
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:November 18, 2015Unknown status
Condition(s):Lymphoma, Large B-cell, DiffuseLast Updated:August 7, 2019Active, not recruiting
Condition(s):Lymphoma, Large B-cell, DiffuseLast Updated:August 7, 2019Active, not recruiting
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:April 15, 2016Completed
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:October 10, 2016Unknown status
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:April 21, 2020Active, not recruiting
Condition(s):Lymphoma, Large B-cell, DiffuseLast Updated:September 22, 2011Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.